Hepatitis B viral infection and role of alcohol

Manuel Muro, Aurelia Collados-Ros, Isabel Legaz

Abstract End-stage liver disease is frequently caused by hepatitis B virus (HBV) and alcohol consumption. Notably, the mechanism by which alcohol affects the course of HBV-associated liver disease is unknown, and additional research is needed in this area. A reduced immunological response, oxidative stress, endoplasmic reticulum stress, Golgi apparatus stress, and enhanced HBV replication are a few potential causes.

Key Words: Hepatitis B virus; Alcohol; Hepatocarcinoma; Immunity; Liver disease

TO THE EDlTOR

We have read with great attention and special interest the review by Ganesan and collaborators entitled“Role of alcohol in the pathogenesis of hepatitis B virus (HBV) infection”[1]. The authors examine the potential mechanisms by which alcohol results in an increased risk of HBV-associated liver disease.HBV infection combined with alcohol usage accelerates the progression of liver damage[2,3], primarily hepatocellular carcinoma, the fifth most common type of cancer. The mechanisms behind these adverse effects of alcohol in HBV-positive patients are unknown. Chronic alcohol consumption changes the architecture of the liver and reduces its functional capability.

The effects of alcohol metabolism on protein function, DNA, immune system changes, and oxidative stress impact both hepatocytes and other liver cells. Because the liver is the central location for the replication of hepatotropic viruses (HCV and HBV), ethanol metabolism is linked to viral hepatitis[4,5].

Regarding the immune system, the early stages of viral infections result in the generation of interferon (IFN) type 1 and the activation of natural killer (NK) cells. IFN type 1 and other antiviral cytokines, which HBV induces, are not particularly efficient. According to various investigations of persistent HBV infection, NK cells exhibit varying alterations in quantity, phenotype, and/or function.HBV-infected hepatocytes are cleared more quickly when activated NK cells are present. However,when chronic infection progresses, the tolerogenic actions of liver ligands and cytokines can inhibit both NK and T cells, limiting their antiviral activity[6,7]. According to reports, alcohol has an impact on NK cell antiviral activity during acute HBV infection[8].

The large, medium, and small forms of HBsAg, as well as the hepatitis B virus core antigen (HBcAg)and hepatitis B e antigen (HBeAg), can all be targeted by polyclonal antibodies produced by B cells in chronic HBV-infected patients[9]. During acute HBV infection, distinct antibodies are produced against the HBV surface antigen and the HBV core antigen. Anti-HBc is a marker for current or past infection,whereas anti-HBs signifies sickness remission[10]. Alcohol may reduce the number of B cells, decreasing HBV antibodies by weakening B cell immunological responses[11].

The B cell response to acute HBV infection is less well understood, but HBV-specific CD4+ and CD8+T cell-mediated responses usually become detectable as HBV replication increases exponentially[12,13].Numerous studies have demonstrated a substantial correlation and link between acute hepatitis, CD4+T cell response, and viral shedding[14-16].

Cytotoxic T lymphocytes (CTLs) that express particular T cell receptors are in charge of eliminating HBV-infected hepatocytes in HBV infection. CTL activation may be diminished, which thus prevents clearance of HBV-infected hepatocytes when the viral peptide/MHC class I complex display in HBVinfected hepatocytes is compromised[17]. The body's capacity to eliminate HBV may be diminished due to ethanol consumption, allowing the virus to persist and eventually produce end-stage liver disorders such as cirrhosis and hepatocellular carcinoma.

The immune response in the liver is meticulously regulated by signals from the commensal microbiota in the gut. Additionally, drinking alcohol causes the close connections between intestinal epithelial cells to weaken, allowing germs to enter the bloodstream and cause an infection[18-20].

However, hepatic metabolism of ethanol may increase the production of reactive oxygen species(ROS), principally hydrogen peroxide and superoxide anion[21].

Recent studies have shown that the ethanol metabolite acetaldehyde can suppress proteasome activity, which is essential for producing antigenic peptides for MHC class I-restricted antigen presentation and can also cause lipid peroxidation, the formation of protein adducts with 4-hydroxynonenal and malonaldehydes (oxidative stress markers). This reduces the HBV-MHC peptide class I complex exposure to CTL identification and restricts the removal of infected cells[1], which causes HBV persistence and ensuing end-stage liver disease. HBV and alcohol addiction stresses the endoplasmic reticulum (ER), and these two stresses may have additive or synergistic effects. Alcohol has been shown to synergistically cause ER stress when other substances, the environment, or a viral illness are present[22]. The increase in HBV DNA, HbsAg, and HBx protein caused by alcohol may be the mechanism by which alcohol induces ER stress in HBV infection. A strained Golgi apparatus frequently matches a stressed ER.

Further study in this area is required since the interaction of alcohol misuse and HBV infection can be harmful. Future research should examine how alcohol metabolism affects innate IFN responses and IFN-stimulated gene activation throughout the pathogenesis of HBV infection, as well as if IFN therapy might be an effective treatment option for alcoholics with HBV infection.

Additionally, there is a significant gap between the role of alcohol in controlling B cell function and its contribution to the pathogenesis of HBV, necessitating further research in this area. To fully comprehend the processes of alcohol-induced impairment and investigate the effects of ethanol on MHC class II presentation, which is mainly catalyzed by effector cells, additional studies examining the relationship between alcohol and HBV adaptive immune response are required.

FOOTNOTES

Author contributions:Muro M and Legaz I designed the research; Collados-Ros A performed the research; Legaz I,Collados-Ros A, and Muro M wrote the letter; Muro M and Legaz I revised the letter.

Conflict-of-interest statement:There are no conflicts of interest to report.

Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Country/Territory of origin:Spain

ORClD number:Manuel Muro 0000-0001-9987-0994; Isabel Legaz 0000-0002-1140-4313.

S-Editor:Chen YL

L-Editor:Wang TQ

P-Editor:Chen YL